Related references
Note: Only part of the references are listed.Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
Ren-Di Jiang et al.
CELL (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Zhou et al.
CELL HOST & MICROBE (2020)
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Annsea Park et al.
CELL HOST & MICROBE (2020)
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Barry Rockx et al.
SCIENCE (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
Coronavirus vaccines: key questions
Ewen Callaway
NATURE (2020)
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Linlin Bao et al.
NATURE (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Mingfeng Liao et al.
NATURE MEDICINE (2020)
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment
Jing Sun et al.
CELL (2020)
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan et al.
CELL (2020)
Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
Mieke Metzemaekers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Type I Interferons in Autoimmune Disease
Mary K. Crow et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
Type I interferons instigate fetal demise after Zika virus infection
Laura J. Yockey et al.
SCIENCE IMMUNOLOGY (2018)
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
Ioanna E. Galani et al.
IMMUNITY (2017)
Type I interferons as Regulators of Lung inflammation
Spyridon Makris et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Evolution of Antiviral Defense Systems
Benjamin R. tenOever
CELL HOST & MICROBE (2016)
The Roles of Type I Interferon in Bacterial Infection
Gayle M. Boxx et al.
CELL HOST & MICROBE (2016)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease
Padmini S. Pillai et al.
SCIENCE (2016)
Rapid generation of a mouse model for Middle East respiratory syndrome
Jincun Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Pathogenic potential of interferon αβ in acute influenza infection
Sophia Davidson et al.
NATURE COMMUNICATIONS (2014)
Type I Interferon Signaling Regulates Ly6Chi Monocytes and Neutrophils during Acute Viral Pneumonia in Mice
Sang-Uk Seo et al.
PLOS PATHOGENS (2011)
Regulation of Adaptive Immunity by the Innate Immune System
Akiko Iwasaki et al.
SCIENCE (2010)
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
Craig W. Day et al.
VIROLOGY (2009)
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Mark J. Cameron et al.
JOURNAL OF VIROLOGY (2007)
A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice
Anjeanette Roberts et al.
PLOS PATHOGENS (2007)
Type I inteferon gene induction by the interferon regulatory factor family of transcription factors
Kenya Honda et al.
IMMUNITY (2006)
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
K Jooss et al.
GENE THERAPY (2003)
Share Paper
